Methyl 3-methyl-2-(3-oxo-2,3-dihydroisoxazol-5-yl)butanoate, 98%, 250mg

Octadecyl 3-(3-(tert-butyl)-4-hydroxyphenyl)propanoate, 95%, 250mg

2-(4-Bromo-1H-indol-3-yl)acetic acid, 95.0%, 1g

Na-Benzyl-Na-methyl-D-alanine methyl ester hydrochloride, 99.0%, 1g

3-Cyano-5-nitro-benzoic acid methyl ester, 98.0%, 1g

3-Bromo-2,4-dimethylpyridine, 95.0%, 1g

5-{4-[2-(5-Ethyl-pyridin-2-yl)-ethoxy]-benzyl}-thiazolidine-2,4-dione hydrochloride, 97.0%, 5g

1-(2-aminoethoxy)-3,5-dimethylbenzene hydrochloride, 95.0%, 10g

4-(Trifluoromethyl)benzo[b]thiophene-2-carboxylic acid, 95.0%, 10g

Formamide, min 99,5 %, pa, ACS, 1 l, emballage en verre

HEXETIDINE, 95%, 250mg

(3S,4R)-3-Fluoro-4-methoxypiperidine hydrochloride, 98%, 500mg

Methyl(2-methylprop-2-en-1-yl)amine hydrochloride, 250mg